Tea flavonols in cardiovascular disease and cancer epidemiology

Proceedings of the Society for Experimental Biology and Medicine

Volumn 220, Issue 4, 1999, Pages 198-202

  Hollman, Peter C H ^a   Feskens, Edith J M ^b   Katan, Martijn B ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FLAVONOL DERIVATIVE;

ANTIOXIDANT ACTIVITY; CANCER; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIETARY INTAKE; DISEASE COURSE; FOOD COMPOSITION; HEART PROTECTION; OXIDATIVE STRESS; TEA;

ANIMALIA;

EID: 0032999370     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-33.x     Document Type: Conference Paper

References (29)

1. Middleton E, Kandaswami C. The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation, and cancer. In: Harborne JB, Ed. The Flavonoids, Advances in Research Since 1986. London: Chapman & Hall, pp619-652, 1994.
2. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52 (Suppl):2085S-2091S, 1992.
3. Kandaswami C, Middleton E Jr. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 366:351-376, 1994.
4. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 344:721-724, 1994.
5. Shaikh M, Martini S, Quiney JR, Baskerville P, La Ville AE, Browse NL, Duffield R, Turner PR, Lewis B. Modified plasma-derived lipoproteins in human atherosclerotic plaques. Atherosclerosis 69:165-172, 1988.
6. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15:441-145, 1995.
7. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992.
8. Mangiapane H. The inhibition of the oxidation of low-density lipoprotein by (+)-catechin, a naturally occurring flavonoid. Biochem Pharmacol 43:445-150, 1992.
9. Nègre-Salvayre A, Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radic Biol Med 12:101-106, 1992.
10. de Whalley C, Rankin SM, Hoult JRS, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low-density lipoproteins by macrophages. Biochem Pharmacol 39:1743-1750, 1990.
11. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933-956, 1996.
12. Wu T-W, Fung K-P, Wu J, Yang C-C, Lo J, Weisel RD. Morin hydrate inhibits azo-initiator-induced oxidation of human low-density lipoprotein. Life Sci 58:17-22, 1996.
13. Kühnau J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 24:117-191, 1976.
14. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40:2379-2383, 1992.
15. Hertog MGL, Hollman PCH, van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions wines and fruit juices. J Agric Food Chem 41:1242-1246, 1993.
16. Hertog MGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 20:21-29, 1993.
17. Hollman PCH, Katan MB. Absorption, metabolism, and bioavailability of flavonoids. In: Packer L, Rice-Evans C, Eds. Flavonoids in Health and Disease. New York: Marcel Dekker Inc., pp483-522.
18. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 22:175-184, 1994.
19. Goldbohm RA, van den Brandt PA, Hertog MGL, Brants HAM, van Poppel G. Flavonoid intake and risk of cancer: A prospective cohort study. Am J Epidemiol 141 (Suppl):s61, 1995.
20. Knekt P, Järvinen R, Seppänen R, Heliövaara M, Teppo L, Pukkala E, Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146:223-230, 1997.
21. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 155:381-386, 1995.
22. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342:1007-1011, 1993.
23. Hertog MGL, Feskens EJM, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 349:699, 1997.
24. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Flavonoids, antioxidant vitamins and risk of stroke: The Zutphen study. Arch Intern Med 156:637-642, 1996.
25. Knekt P, Jèrvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: A cohort study. Br Med J 312:478-481, 1996.
26. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125:384-389, 1996.
27. Hertog MGL, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: The Caerphilly Study. Am J Clin Nutr 65:1489-1494, 1997.
28. van het Hof KH, Kivits GAA, Weststrate JA, Tijburg LBM. Bioavailability of catechins from tea: The effect of milk. Eur J Clin Nutr 52:356-359, 1998.
29. Katan MB. Flavonoids and heart disease. Am J Clin Nutr 65:1542-1543, 1997.